Last updated: September 26, 2023
Sponsor: I.M. Sechenov First Moscow State Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
electrocardiography, echocardiography with the determination of global longitudinal strain, cardiopulmonary exercise test, and diagnostic of endothelial function by Angioscan
Clinical Study ID
NCT05508087
2409
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subject being over 18 yers of age
- Subject expected for high dose chemotherapy and hematopoietic cell transplantation
Exclusion
Exclusion Criteria:
- Subject's refusal
Study Design
Total Participants: 150
Treatment Group(s): 1
Primary Treatment: electrocardiography, echocardiography with the determination of global longitudinal strain, cardiopulmonary exercise test, and diagnostic of endothelial function by Angioscan
Phase:
Study Start date:
July 17, 2019
Estimated Completion Date:
December 01, 2024
Study Description
Connect with a study center
Sechenov University
Moscow,
Russian FederationActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.